Part D drug consolidation could save Medicare $150 million, CMS finds

Share this article:

Consolidating drugs covered by Medicare Part B and Part D under Part D could save Medicare nearly $150 million, according to a new report from the Centers for Medicare & Medicaid Services.

By contrast, the report found that consolidating drugs under Medicare Part B could increase Medicare spending by $52 million. 

Though the vast majority of drugs for seniors are covered under the Medicare Part D program, there are still some drugs covered through Part B. These drugs include injectable insulin, certain vaccines—including for influenza—and drugs dispensed by nebulizer.

While the consolidation under Medicare Part D could save the program money, it would adversely impact Medicare beneficiaries in the pocketbook, the report found. Because Part D has “less generous coverage rules,” switching the coverage of drugs from Part B to Part D would cost beneficiaries roughly $267 in added out-of-pocket expenses. 

Share this article:

More in News

Skilled nursing facility trends contribute to improved Medicare outlook, Congressional report says

The Medicare trust fund is on track to remain solvent until 2030, trustees of the program stated in a Congressional report released Monday. This improved outlook is due in part to revised expectations about the case mix in skilled nursing facilities.

House bill would define, promote coordinated long-term care services

A bill introduced in the House of Representatives would target improved care coordination for seniors, also adding it under the Older Americans Act.

Seize the day: Tech Awards deadline is tomorrow

Seize the day: Tech Awards deadline is tomorrow

The final countdown has begun: Long-term care providers have less than 48 hours to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted through July 30.